Author Details

Палтуев, Р. М

Issue	Section	Title	File
No 1S (2009)	Articles	ANTIANGIOGENNYE PREPARATY V LEChENII RAKA MOLOChNOY ZhELEZY
No 8 (2013)	Articles	ROL' IMMUNOKON\"YuGATOV V TARGETNOY TERAPII ZLOKAChESTVENNYKh OPUKhOLEY
No 8 (2015)	Articles	KOMPLEKSNAYa TERAPIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
No 8 (2016)	Articles	NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
No 17 (2016)	Articles	TAXANES IN THE TREATMENT OF BREAST CANCER
No 17 (2017)	Articles	De-escalation and escalation of treatment of patients with HER2-positive breast cancer
No 17 (2017)	Articles	New possibilities of the treatment of breast cancer: microtubule inhibitors
No 7 (2018)	Articles	GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER
No 12 (2018)	Articles	Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities
Vol 27, No 7 (2020)	Articles	Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study
Vol 27, No 7 (2020)	Articles	Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors
Vol 29, No 7 (2022)	Articles	Clinical immunology of breast cancer
Vol 29, No 7 (2022)	Articles	Predictive and prognostic role of tumor-infiltrating lymphocytes (TILs) in early triple-negative breast cancer